Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
2017 Aug 5;105:11-17. doi: 10.1016/j.bone.2017.08.003. [Epub ahead of print] Review. CONCLUSION: There appears to be an increased risk of multiple vertebral fractures after discontinuation of denosumab although strong evidence for such an effect and for … Leer más